{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T19:19:39Z","timestamp":1789759179346,"version":"4.0.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.brainres.2013.01.046","type":"journal-article","created":{"date-parts":[[2013,2,13]],"date-time":"2013-02-13T03:52:51Z","timestamp":1360727571000},"page":"61-67","source":"Crossref","is-referenced-by-count":84,"special_numbering":"C","title":["A ketogenic diet improves motor performance but does not affect \u03b2-amyloid levels in a mouse model of Alzheimer's Disease"],"prefix":"10.1016","volume":"1505","author":[{"given":"Tina L.","family":"Beckett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christa M.","family":"Studzinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey N.","family":"Keller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Paul Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana M.","family":"Niedowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainres.2013.01.046_bib1","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1365-2125.2010.03830.x","article-title":"Diabetes mellitus and Alzheimer's disease: shared pathology and treatment?","volume":"71","author":"Akter","year":"2011","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.brainres.2013.01.046_bib2","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.2353\/ajpath.2006.051223","article-title":"Beta-amyloid mediated nitration of manganese superoxide dismutase: implication for oxidative stress in a APPNLH\/NLH X PS-1P264L\/P264L double knock-in mouse model of Alzheimer's disease","volume":"168","author":"Anantharaman","year":"2006","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.brainres.2013.01.046_bib3","first-page":"31","article-title":"Light and electron microscopic localization of beta-amyloid protein in muscle biopsies of patients with inclusion-body myositis","volume":"141","author":"Askanas","year":"1992","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.brainres.2013.01.046_bib4","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1073\/pnas.93.3.1314","article-title":"Transfer of beta-amyloid precursor protein gene using adenovirus vector causes mitochondrial abnormalities in cultured normal human muscle","volume":"93","author":"Askanas","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1016\/j.brainres.2013.01.046_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jnen\/60.1.1","article-title":"Inclusion-body myositis: newest concepts of pathogenesis and relation to aging and Alzheimer disease","volume":"60","author":"Askanas","year":"2001","journal-title":"J Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.brainres.2013.01.046_bib6","doi-asserted-by":"crossref","first-page":"3410","DOI":"10.1073\/pnas.0507313103","article-title":"AMPA receptor downscaling at the onset of Alzheimer's disease pathology in double knockin mice","volume":"103","author":"Chang","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.brainres.2013.01.046_bib7","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S1474-4422(04)00681-7","article-title":"Insulin and neurodegenerative disease: shared and specific mechanisms","volume":"3","author":"Craft","year":"2004","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.brainres.2013.01.046_bib8","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2174\/156720507780362137","article-title":"Insulin resistance and Alzheimer's disease pathogenesis: potential mechanisms and implications for treatment","volume":"4","author":"Craft","year":"2007","journal-title":"Curr Alzheimer Res."},{"key":"10.1016\/j.brainres.2013.01.046_bib9","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0002-9440(10)65682-9","article-title":"Amyloid-beta deposition in skeletal muscle of transgenic mice: possible model of inclusion body myopathy","volume":"153","author":"Fukuchi","year":"1998","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.brainres.2013.01.046_bib10","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1126\/science.1062097","article-title":"Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils","volume":"293","author":"Gotz","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.brainres.2013.01.046_bib11","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.nurt.2008.05.004","article-title":"Ketone bodies as a therapeutic for Alzheimer's disease","volume":"5","author":"Henderson","year":"2008","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.brainres.2013.01.046_bib12","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ajpath.2011.09.034","article-title":"BACE2 expression increases in human neurodegenerative disease","volume":"180","author":"Holler","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.brainres.2013.01.046_bib13","doi-asserted-by":"crossref","first-page":"11950","DOI":"10.1523\/JNEUROSCI.3916-08.2008","article-title":"Amyloid-beta peptide (Abeta) neurotoxicity is modulated by the rate of peptide aggregation: a beta dimers and trimers correlate with neurotoxicity","volume":"28","author":"Hung","year":"2008","journal-title":"J Neurosci."},{"key":"10.1016\/j.brainres.2013.01.046_bib14","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/S0002-9440(10)65681-7","article-title":"Transgenic mice over-expressing the C-99 fragment of betaPP with an alpha-secretase site mutation develop a myopathy similar to human inclusion body myositis","volume":"153","author":"Jin","year":"1998","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.brainres.2013.01.046_bib15","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nn.2785","article-title":"Abeta(1-42) inhibition of LTP is mediated by a signaling pathway involving caspase-3, Akt1 and GSK-3beta","volume":"14","author":"Jo","year":"2011","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.brainres.2013.01.046_bib16","doi-asserted-by":"crossref","first-page":"5440","DOI":"10.1073\/pnas.97.10.5440","article-title":"D-beta-hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease","volume":"97","author":"Kashiwaya","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.brainres.2013.01.046_bib17","article-title":"A ketone ester diet exhibits anxiolytic and cognition-sparing properties, and lessens amyloid and tau pathologies in a mouse model of Alzheimer's disease","author":"Kashiwaya","year":"2012","journal-title":"Neurobiol. Ageing"},{"key":"10.1016\/j.brainres.2013.01.046_bib18","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1126\/science.1058189","article-title":"Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP","volume":"293","author":"Lewis","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.brainres.2013.01.046_bib19","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1097\/01.jnen.0000228204.19915.69","article-title":"Proteomic analysis of inclusion body myositis","volume":"65","author":"Li","year":"2006","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.brainres.2013.01.046_bib20","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1111\/j.1471-4159.2005.03647.x","volume":"96","author":"Mohmmad Abdul","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2013.01.046_bib21","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.nbd.2007.06.002","article-title":"Abeta solubility and deposition during AD progression and in APPxPS-1 knock-in mice","volume":"27","author":"Murphy","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.brainres.2013.01.046_bib22","doi-asserted-by":"crossref","first-page":"23380","DOI":"10.1074\/jbc.271.38.23380","article-title":"Enhanced amyloidogenic processing of the beta-amyloid precursor protein in gene-targeted mice bearing the Swedish familial Alzheimer's disease mutations and a \u201chumanized\u201d Abeta sequence","volume":"271","author":"Reaume","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.brainres.2013.01.046_bib23","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1097\/00001756-199306000-00055","article-title":"beta-Amyloid precursor protein mRNA is increased in inclusion-body myositis muscle","volume":"4","author":"Sarkozi","year":"1993","journal-title":"Neuroreport"},{"key":"10.1016\/j.brainres.2013.01.046_bib24","doi-asserted-by":"crossref","first-page":"8717","DOI":"10.1523\/JNEUROSCI.20-23-08717.2000","article-title":"Presenilin-1 P264L knock-in mutation: differential effects on abeta production, amyloid deposition, and neuronal vulnerability","volume":"20","author":"Siman","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2013.01.046_bib25","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.brainres.2008.06.005","article-title":"Induction of ketosis may improve mitochondrial function and decrease steady-state amyloid-beta precursor protein (APP) levels in the aged dog","volume":"1226","author":"Studzinski","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2013.01.046_bib26","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/j.1471-4159.2008.05798.x","article-title":"Effects of short-term Western diet on cerebral oxidative stress and diabetes related factors in APP x PS1 knock-in mice","volume":"108","author":"Studzinski","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2013.01.046_bib27","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1743-7075-2-28","article-title":"A ketogenic diet reduces amyloid beta 40 and 42 in a mouse model of Alzheimer's disease","volume":"2","author":"Van der Auwera","year":"2005","journal-title":"Nutr. Metab."},{"key":"10.1016\/j.brainres.2013.01.046_bib28","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/S0002-9440(10)64644-5","article-title":"Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the london mutant of human APP in neurons","volume":"157","author":"Van Dorpe","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.brainres.2013.01.046_bib29","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.plefa.2003.09.007","article-title":"The therapeutic implications of ketone bodies: the effects of ketone bodies in pathological conditions: ketosis, ketogenic diet, redox states, insulin resistance, and mitochondrial metabolism","volume":"70","author":"Veech","year":"2004","journal-title":"Prostaglandins Leukot Essent Fatty Acids."},{"key":"10.1016\/j.brainres.2013.01.046_bib30","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/416535a","article-title":"Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo","volume":"416","author":"Walsh","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.brainres.2013.01.046_bib31","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.nmd.2006.08.009","article-title":"AbetaPP-overexpression and proteasome inhibition increase alphaB-crystallin in cultured human muscle: relevance to inclusion-body myositis","volume":"16","author":"Wojcik","year":"2006","journal-title":"Neuromuscul. Disord."}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899313001613?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899313001613?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T17:25:35Z","timestamp":1562693135000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899313001613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":31,"alternative-id":["S0006899313001613"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2013.01.046","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}